IRIS Accounts Production v24.3.0.553 13113804 director 1.2.23 31.1.24 31.1.24 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh131138042023-01-31131138042024-01-31131138042023-02-012024-01-31131138042022-01-31131138042022-02-012023-01-31131138042023-01-3113113804ns15:EnglandWales2023-02-012024-01-3113113804ns14:PoundSterling2023-02-012024-01-3113113804ns10:Director12023-02-012024-01-3113113804ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3113113804ns10:SmallEntities2023-02-012024-01-3113113804ns10:AuditExempt-NoAccountantsReport2023-02-012024-01-3113113804ns10:SmallCompaniesRegimeForDirectorsReport2023-02-012024-01-3113113804ns10:SmallCompaniesRegimeForAccounts2023-02-012024-01-3113113804ns10:FullAccounts2023-02-012024-01-3113113804ns10:OrdinaryShareClass12023-02-012024-01-3113113804ns10:OrdinaryShareClass22023-02-012024-01-3113113804ns10:OrdinaryShareClass32023-02-012024-01-3113113804ns5:CurrentFinancialInstruments2024-01-3113113804ns5:CurrentFinancialInstruments2023-01-3113113804ns5:ShareCapital2024-01-3113113804ns5:ShareCapital2023-01-3113113804ns5:RetainedEarningsAccumulatedLosses2024-01-3113113804ns5:RetainedEarningsAccumulatedLosses2023-01-3113113804ns10:RegisteredOffice2023-02-012024-01-3113113804ns5:ComputerEquipment2023-02-012024-01-3113113804ns5:ComputerEquipment2023-01-3113113804ns5:ComputerEquipment2024-01-3113113804ns5:ComputerEquipment2023-01-3113113804ns5:DeferredTaxation2023-01-3113113804ns5:DeferredTaxation2023-02-012024-01-3113113804ns5:DeferredTaxation2024-01-3113113804ns10:OrdinaryShareClass12024-01-3113113804ns10:OrdinaryShareClass22024-01-3113113804ns10:OrdinaryShareClass32024-01-31131138041ns10:Director12023-01-31131138041ns10:Director12022-01-31131138041ns10:Director12023-02-012024-01-31131138041ns10:Director12022-02-012023-01-31131138041ns10:Director12024-01-31131138041ns10:Director12023-01-31
REGISTERED NUMBER: 13113804 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 January 2024

for

EJN Metabolic And Obesity Medical
Services Limited

EJN Metabolic And Obesity Medical
Services Limited (Registered number: 13113804)






Contents of the Financial Statements
for the Year Ended 31 January 2024




Page

Balance Sheet 1

Notes to the Financial Statements 3


EJN Metabolic And Obesity Medical
Services Limited (Registered number: 13113804)

Balance Sheet
31 January 2024

31.1.24 31.1.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 3,814 2,774

CURRENT ASSETS
Cash at bank 52,321 43,153

CREDITORS
Amounts falling due within one year 5 3,922 2,873
NET CURRENT ASSETS 48,399 40,280
TOTAL ASSETS LESS CURRENT
LIABILITIES

52,213

43,054

PROVISIONS FOR LIABILITIES 6 725 738
NET ASSETS 51,488 42,316

CAPITAL AND RESERVES
Called up share capital 7 102 102
Retained earnings 51,386 42,214
SHAREHOLDERS' FUNDS 51,488 42,316

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

EJN Metabolic And Obesity Medical
Services Limited (Registered number: 13113804)

Balance Sheet - continued
31 January 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 29 October 2024 and were signed by:





Dr E J Nicholson - Director


EJN Metabolic And Obesity Medical
Services Limited (Registered number: 13113804)

Notes to the Financial Statements
for the Year Ended 31 January 2024

1. STATUTORY INFORMATION

EJN Metabolic And Obesity Medical Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 13113804

Registered office: C/o Echo Tax, SPACES Manchester
Peter House
Oxford Street
Manchester
M1 5AN

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 25% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


EJN Metabolic And Obesity Medical
Services Limited (Registered number: 13113804)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 February 2023 3,699
Additions 2,619
At 31 January 2024 6,318
DEPRECIATION
At 1 February 2023 925
Charge for year 1,579
At 31 January 2024 2,504
NET BOOK VALUE
At 31 January 2024 3,814
At 31 January 2023 2,774

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.24 31.1.23
£    £   
Tax 2,608 1,757
Directors' current accounts 834 522
Accrued expenses 480 594
3,922 2,873

EJN Metabolic And Obesity Medical
Services Limited (Registered number: 13113804)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024

6. PROVISIONS FOR LIABILITIES
31.1.24 31.1.23
£    £   
Deferred tax 725 738

Deferred
tax
£   
Balance at 1 February 2023 738
Utilised during year (13 )
Balance at 31 January 2024 725

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.1.24 31.1.23
value: £    £   
100 Ordinary A £1 100 100
1 Ordinary B £1 1 1
1 Ordinary C £1 1 1
102 102

8. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 January 2024 and 31 January 2023:

31.1.24 31.1.23
£    £   
Dr E J Nicholson
Balance outstanding at start of year (522 ) (210 )
Amounts advanced 3,000 -
Amounts repaid (3,312 ) (312 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (834 ) (522 )

9. ULTIMATE CONTROLLING PARTY

The controlling party is Dr E J Nicholson.